Discover trends, market shifts, and competitive outlooks for the cancer biomarker industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Is the Estimated Market Size of the Cancer Biomarker Market In 2029?

In recent times, the size of the cancer biomarker market has witnessed significant expansion. Predictions indicate that it will develop from $22.19 billion in 2024 to $25.28 billion in 2025, achieving a compound annual growth rate (CAGR) of 13.9%. The growth observed in the historic period is a reflection of factors such as the transition towards personalized medicine, advancements in immunotherapy, evolution of regulatory frameworks, concerted research initiatives, and an emphasis on non-coding RNAs.

In the coming years, the cancer biomarker market size is anticipated to experience fast-paced growth, with projections estimating it to reach $45.88 billion by 2029, growing at a compound annual growth rate (CAGR) of 16.1%. Factors contributing to this growth during the forecast period include a shift towards patient-centered diagnostic approaches, inclusion of biomarkers in clinical trials, the development of multiplex biomarker panels, exploration of non-coding RNAs, and the gradual commercialization of biomarker tests. Trends expected to shape the market during the forecast period include advancements in genomics, precision medicine strategies, the utilization of liquid biopsies, progression in immunotherapy, and the incorporation of artificial intelligence (AI).

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8492&type=smp

Which Factors and External Forces Are Driving Demand in the Cancer Biomarker Market?

The cancer biomarker market’s progress is propelled by the escalating prevalence of cancer. The incidence rate of cancer refers to the number of newly diagnosed cancers, specific to a certain part or type, in a particular population over a specific year, expressed as cases per 100,000 people at risk. The surging prevalence of cancer is promoting the extensive use of cancer biomarkers due to their ability to evaluate disease risk, screen for hidden primary tumors, distinguish non-cancerous from cancerous symptoms, or differentiate various types of malignancies. For instance, research released by the American Cancer Society, a US-based health entity, in January 2022 showed that the US is estimating about 609,360 cancer-related deaths and roughly 1.9 million fresh cancer diagnoses in 2022, which equates to nearly 1,670 deaths daily. Consequently, the surging prevalence of cancer is projected to stimulate the progress of the cancer biomarker market in the forthcoming years.

Which Segments in the Cancer Biomarker Offer the Most Growth?

The cancer biomarker market covered in this report is segmented –

1) By Biomarkers Type: Protein Biomarkers, Genetic Biomarkers, Other Cancer Biomarkers

2) By Profiling Technologies: Omics Technologies, Imaging Technologies, Immunoassay, Bioinformatics, Cytogenetics

3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Thyroid Cancer, Kidney Cancer, Other Cancers

4) By Application: Diagnostics, Research And Development, Prognostics, Risk Assessment, Other Applications

Subsegments:

1) By Protein Biomarkers: Tumor-Specific Antigens, Circulating Tumor Protein

2) By Genetic Biomarkers: DNA Mutations, RNA Expression Profiles

3) By Other Cancer Biomarkers: Epigenetic Biomarkers, Metabolomic Biomarkers

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=8492&type=smp

What Are the Fastest-Growing Geographies in the Cancer Biomarker Market?

North America was the largest region in the cancer biomaker market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer biomarker market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Cutting-Edge Market Trends Are Expected to Drive theCancer Biomarker Market’s Growth?

The leading firms in the cancer biomarker market are concentrating on the creation of innovative solutions such as cancer biomarkers powered by artificial intelligence. These are biological markers of cancer which are detected and analyzed using AI technologies to increase diagnostic precision and provide personalized treatment plans for patients. For example, in September 2023, a US-based company called Ibex Medical Analytics introduced Galen Breast HER2, a solution driven by AI that is meant to improve the reliability and accuracy of HER2 scoring in individuals with breast cancer. The new platform assists pathologists by identifying invasive tumor areas automatically and calculating the expression of HER2 according to the 2018 ASCO/CAP guidelines. The Galen Breast HER2 system employs a unique computational pipeline to assess immunohistochemistry (IHC)-stained slides, offering comprehensive visualizations of staining patterns. This allows pathologists to make well-informed decisions on treatment.

View the full report here:

https://www.thebusinessresearchcompany.com/report/cancer-biomarker-global-market-report

What Are the Key Elements That Define the Cancer Biomarker Market?

A cancer biomarker refers to a biological molecule present in the blood, tissues, or other bodily fluids, that indicates the presence of normal or abnormal activity, as well as a condition or disease. Cancer biomarkers are used to characterize alterations in the tumor.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8492

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model